Related Experiment Videos
Oncogenic signaling
Abstract:
Cancer develops when one or more cells begin to grow uncontrollably, presumably as a result of alterations in the highly regulated processes of normal cell division. These changes may result from germline or somatic mutations in genes that control normal cell proliferation, resulting in oncogenes. Oncogenes--originally defined as viral genes that transformed mammalian host cells--code for proteins with diverse functions. Antioncogenes, or tumor-suppressor genes, code for proteins acting as brakes in the cell cycle. Mutations in or deletions of these genes release the brakes. An overview of cellular signaling pathways, how they may be altered in cancers, and recently reported clinical implications of abnormal expression of some oncogenes and tumor-suppressor genes will be presented here.
Insights
Cancer arises from uncontrolled cell growth due to mutations in cell division genes. Understanding oncogenes and tumor-suppressor genes reveals how these genetic alterations drive cancer progression and offers clinical insights.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Cancer is characterized by uncontrolled cell proliferation, stemming from disruptions in normal cell division.
- Genetic alterations, including germline or somatic mutations, are fundamental to cancer development.
Purpose of the Study:
- To provide an overview of cellular signaling pathways involved in cancer.
- To explain how these pathways are altered in cancerous cells.
- To discuss the clinical implications of aberrant oncogene and tumor-suppressor gene expression.
Main Methods:
- Review of existing literature on cell cycle regulation, oncogenes, and tumor-suppressor genes.
- Analysis of cellular signaling pathways implicated in cancer.
- Examination of clinical data related to gene expression in cancer patients.
Main Results:
- Oncogenes (viral genes inducing cell transformation) and tumor-suppressor genes (cell cycle regulators) play critical roles.
- Mutations or deletions in tumor-suppressor genes release cell cycle control, promoting proliferation.
- Altered signaling pathways and abnormal gene expression have significant clinical relevance.
Conclusions:
- Understanding the molecular basis of cancer, particularly the roles of oncogenes and tumor-suppressor genes, is crucial.
- Aberrant cellular signaling and genetic mutations drive tumorigenesis.
- Knowledge of these mechanisms informs clinical strategies for cancer treatment and management.